18

公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 2: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 3: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 4: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 5: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 6: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 7: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 8: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 9: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 10: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 11: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 12: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 13: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 14: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 15: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 16: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 17: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning
Page 18: 公益財団法人 放射線影響研究所 RERFSecure Site exposure and the prevalence of prostatic adeno- carcinoma at autopsy and secondly, to provide additional information concerning